Non-Clinical Kennedy Institute Studentships
Applications close on Tuesday 3 December 2024.
2025 KIR Non Clinical
ID | Title | Supervisors | Phase |
---|---|---|---|
KIR-NC-01 KIR-NC-01 | Resident memory B cell responses in the lung; immunity against pulmonary pathogens Resident memory B cell responses in the lung; immunity against pulmonary pathogens | Tal Arnon, Michael Dustin | 2025 KIR Non Clinical |
KIR-NC-02 KIR-NC-02 | How inflammatory macrophages instruct innate effector responses in the tumour microenvironment? How inflammatory macrophages instruct innate effector responses in the tumour microenvironment? | Jelena Bezbradica Mirkovic, Audrey Gérard | 2025 KIR Non Clinical |
KIR-NC-03 KIR-NC-03 | Engineering Resolution – mRNA targeting of chronic inflammatory disease Engineering Resolution – mRNA targeting of chronic inflammatory disease | Mark Coles, Christopher Buckley | 2025 KIR Non Clinical |
KIR-NC-04 KIR-NC-04 | Investigating cross-tissue and cross-disease immune mechanisms using single-cell/spatial multiomics & machine learning/AI-powered language learning tools Investigating cross-tissue and cross-disease immune mechanisms using single-cell/spatial multiomics & machine learning/AI-powered language learning tools | Calliope Dendrou | 2025 KIR Non Clinical |
KIR-NC-05 KIR-NC-05 | Mechanical force matters in T-cell activation Mechanical force matters in T-cell activation | Marco Fritzsche, Michael Dustin, Huw Colin-York | 2025 KIR Non Clinical |
KIR-NC-06 KIR-NC-06 | Relationship between Tumour microenvironment and atherosclerotic cardiovascular disease during immunotherapy Relationship between Tumour microenvironment and atherosclerotic cardiovascular disease during immunotherapy | Audrey Gérard, Claudia Monaco | 2025 KIR Non Clinical |
KIR-NC-07 KIR-NC-07 | Harnessing human genomic, transcriptomic and proteomic data to identify novel therapeutic targets Harnessing human genomic, transcriptomic and proteomic data to identify novel therapeutic targets | Yang Luo, Jagdeep Nanchahal, Esther Ng | 2025 KIR Non Clinical |
KIR-NC-08 KIR-NC-08 | How do secreted phospho-proteins dictate fibroblast-neutrophil crosstalk in treatment resistant inflammatory bowel disease? How do secreted phospho-proteins dictate fibroblast-neutrophil crosstalk in treatment resistant inflammatory bowel disease? | Kim Midwood, Fiona Powrie FRS, Holm Uhlig, Anna Hoyle | 2025 KIR Non Clinical |
KIR-NC-09 KIR-NC-09 | Unraveling the intersection of immune responses in gut and cardiovascular and health Unraveling the intersection of immune responses in gut and cardiovascular and health | Claudia Monaco, Fiona Powrie FRS, Jennifer Cole | 2025 KIR Non Clinical |
KIR-NC-10 KIR-NC-10 | Identification of novel therapeutic pathways for lung fibrosis and repair Identification of novel therapeutic pathways for lung fibrosis and repair | Jagdeep Nanchahal, Kim Midwood, Lynn Williams | 2025 KIR Non Clinical |
KIR-NC-11 KIR-NC-11 | Microbiome metabolites as immune checkpoints Microbiome metabolites as immune checkpoints | Fiona Powrie FRS, Holm Uhlig, Alice Bertocchi | 2025 KIR Non Clinical |
KIR-NC-12 KIR-NC-12 | Shaping intestinal inflammation by neutrophils: the host-diet-microbiome triad Shaping intestinal inflammation by neutrophils: the host-diet-microbiome triad | Irina Udalova, Fiona Powrie FRS, Jethro Johnson, Linh Nguyen | 2025 KIR Non Clinical |
KIR-NC-13 KIR-NC-13 | How does ageing influence intrinsic cartilage repair in osteoarthritis? How does ageing influence intrinsic cartilage repair in osteoarthritis? | Tonia Vincent, Ghada Alsaleh, Linyi Zhu | 2025 KIR Non Clinical |